Skip to main content
Premium Trial:

Request an Annual Quote

GCI, AnVil To Probe Arthritis Gene Expression

NEW YORK, April 24-AnVil and Genomics Collaborative will be working together on a pilot project to apply new data analysis and visualization systems to microarray data, AnVil said in a statement today.

In the project, AnVil will apply its visualization and analysis tools to GCI's DNA microarray data.

The partnership is designed to help GCI identify gene expression patterns that could suggest new drug targets for inflammatory disease, especially rheumatoid arthritis.

AnVil, based in Burlington, Mass., is a privately held bioinformatics company.

GCI is a functional genomics company that has developed a large-scale database of linked clinical data, including DNA, sera, tissue samples and patient information.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.